Search

Your search keyword '"Musallam, KM"' showing total 225 results

Search Constraints

Start Over You searched for: Author "Musallam, KM" Remove constraint Author: "Musallam, KM"
225 results on '"Musallam, KM"'

Search Results

1. Profile of Luspatercept in the Treatment of Anemia in Adults with Non-Transfusion-Dependent β-Thalassemia (NTDT): Design, Development and Potential Place in Therapy

2. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

3. Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021

4. Prevalence and risk factors for pulmonary arterial hypertension in a large group of β-thalassemia patients using right heart catheterization: a Webthal study

5. Prevalence and Risk Factors for Pulmonary Arterial Hypertension in a Large Group of β-Thalassemia Patients Using Right Heart Catheterization: A Webthal(R) Study

11. Primary colorectal lymphoma.

15. Small bowel intussusception following blunt abdominal trauma in an adult patient.

19. Tricuspid-valve regurgitant jet velocity as a risk factor for death in β-thalassemia

21. Long-term improvement in cardiac magnetic resonance in β-thalassemia major patients treated with deferasirox extends to patients with abnormal baseline cardiac function

22. Trans-acting genetic modifiers of clinical severity in heterozygous β-Thalassemia trait.

23. Anemia and iron overload as prognostic markers of outcomes in β-thalassemia.

24. Revisiting iron overload status and change thresholds as predictors of mortality in transfusion-dependent β-thalassemia: a 10-year cohort study.

25. Differential effects of iron chelators on iron burden and long-term morbidity and mortality outcomes in a large cohort of transfusion-dependent β-thalassemia patients who remained on the same monotherapy over 10 years.

26. Quality of life, mood disorders, and cognitive impairment in adults with β-thalassemia.

28. Systematic review and evidence gap assessment of the clinical, quality of life, and economic burden of alpha-thalassemia.

30. Αlpha-thalassemia: A practical overview.

31. 'Phenoconversion' in adult patients with β-thalassemia.

32. How I treat non-transfusion-dependent β-thalassemia.

33. Arab Countries and Oncology Clinical Trials: A Bibliometric Analysis.

34. Epidemiology of clinically significant forms of alpha- and beta-thalassemia: A global map of evidence and gaps.

35. Luspatercept for transfusion-dependent β-thalassemia: time to get real.

37. Psychometric evaluation of the NTDT-PRO questionnaire for assessing symptoms in patients with non-transfusion-dependent beta-thalassaemia.

38. Overall and complication-free survival in a large cohort of patients with β-thalassemia major followed over 50 years.

39. Development of a Thalassemia International Prognostic Scoring System (TIPSS).

42. Right in time: Mitapivat for the treatment of anemia in α- and β-thalassemia.

43. Luspatercept for the treatment of anaemia in non-transfusion-dependent β-thalassaemia (BEYOND): a phase 2, randomised, double-blind, multicentre, placebo-controlled trial.

45. Clinical burden of hemophilia in older adults: Beyond bleeding risk.

46. Mortality in β-thalassemia patients with confirmed pulmonary arterial hypertension on right heart catheterization.

47. Thalassemia and autoimmune diseases: Absence of evidence or evidence of absence?

48. Risk of mortality from anemia and iron overload in nontransfusion-dependent β-thalassemia.

50. Primary HBB gene mutation severity and long-term outcomes in a global cohort of β-thalassaemia.

Catalog

Books, media, physical & digital resources